AHA today urged the Centers for Medicare & Medicaid Services to immediately withdraw its Most Favored Nation model interim final rule and “replace it with a serious effort at drug pricing reform.” 

Effective Jan. 1 for most hospitals, the interim final rule cuts payments for certain Medicare Part B drugs and biologicals to no more than the lowest price that drug manufacturers receive in other similar countries.  

“Instead of directly tackling the skyrocketing cost of drugs, this rule puts hospitals in the untenable position of having to divert resources from other patient care simply to buy the drug therapies they need for their patients,” AHA wrote. “And instead of enacting thoughtful policies that attempt to lower drug prices, this rule puts patients at risk. Indeed, CMS itself states that it expects beneficiaries’ access to drugs to be impeded, requiring them to accept less-effective treatments or forgo or postpone necessary care. In addition, the agency makes the breathtaking estimate that, within three years, nearly one in five Medicare Part B enrollees may have no access to drugs subject to the MFN rule.”

The AHA last month filed a declaration supporting other organizations seeking a temporary restraining order and preliminary injunction to prevent the rule from cutting payments for certain Medicare Part B drugs and biologicals. 

Related News Articles

Headline
Medicare patients who receive care in a hospital outpatient department are more likely to be poorer and have more severe chronic conditions than Medicare…
Headline
The House of Representatives last night voted 384-38 to pass a bill that, among other health care provisions, would eliminate the 2% across-the-board cut…
Headline
The Campaign for Sustainable Rx Pricing today launched a grassroots and digital advertising campaign urging policymakers to lower prescription drug prices…
Blog
The availability of swift, accurate and reliable diagnostic testing during the public health emergency has been extremely important. Lab testing is essential…
Headline
The Medicare Payment Advisory Commission yesterday recommended that Congress require the Centers for Medicare & Medicaid Services to transition to a…
Headline
The U.S. Court of Appeals for the 9th Circuit yesterday stopped data analysis company Integra Med Analytics from proceeding with a False Claims Act lawsuit…